Short- and mid-term outcomes of robotic-assisted total mesorectal excision for the treatment of rectal cancer. Our experience after 198 consecutive cases.

@article{Ruiz2016ShortAM,
  title={Short- and mid-term outcomes of robotic-assisted total mesorectal excision for the treatment of rectal cancer. Our experience after 198 consecutive cases.},
  author={Marcos G{\'o}mez Ruiz and Joaqu{\'i}n Jes{\'u}s Alonso Mart{\'i}n and Carmen Cagigas Fern{\'a}ndez and Jos{\'e} Ignacio Mart{\'i}n Parra and H{\'e}ctor Real Noval and Berta Mart{\'i}n Rivas and E Toledo Mart{\'i}nez and Julio Castillo Diego and Manuel G{\'o}mez Fleitas},
  journal={European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology},
  year={2016},
  volume={42 6},
  pages={848-54}
}
BACKGROUND Robot-assisted total mesorectal excision is a safe alternative for rectal cancer treatment. Nevertheless, substantial data is still missing. Our aim was to assess the perioperative and oncological outcomes of the routine use of the robotic-assisted approach for rectal cancer treatment. PATIENTS AND METHODS 198 Consecutive robotic rectal… CONTINUE READING